Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients.

Lim JU, Kim EK, Lim SY, Lee JH, Lee JS, Lee SD, Oh YM, Rhee CK; KOLD Study Group.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 30;14:3035-3042. doi: 10.2147/COPD.S227377. eCollection 2019.

2.

Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.

Leem AY, Kim YS, Lee JH, Kim TH, Kim HY, Oh YM, Lee SD, Jung JY.

Respir Res. 2019 Dec 9;20(1):279. doi: 10.1186/s12931-019-1241-5.

3.

Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers.

Lee JH, Lee JH, Jo KW, Huh JW, Oh YM, Lee JS.

J Gynecol Oncol. 2020 Jan;31(1):e10. doi: 10.3802/jgo.2020.31.e10. Epub 2019 Aug 5.

4.

Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study.

Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK.

J Thorac Dis. 2019 Oct;11(10):4224-4233. doi: 10.21037/jtd.2019.09.63.

5.

The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.

Kim J, Lee CH, Hwang SS, Kim DK, Yoon HI, Lee SH, Kim KU, Kim EK, Kim TH, Lee JH, Oh YM, Lee SD.

Respiration. 2019;98(6):495-502. doi: 10.1159/000502826. Epub 2019 Oct 30.

PMID:
31665736
6.

Ascorbic Acid 2-Glucoside Stably Promotes the Primitiveness of Embryonic and Mesenchymal Stem Cells Through Ten-Eleven Translocation- and cAMP-Responsive Element-Binding Protein-1-Dependent Mechanisms.

Lee S, Lim J, Lee JH, Ju H, Heo J, Kim Y, Kim S, Yu HY, Ryu CM, Lee SY, Han JM, Oh YM, Lee H, Jang H, Yoon TJ, Ahn HS, Kim K, Kim HR, Roe JS, Chung HM, Son J, Kim JS, Shin DM.

Antioxid Redox Signal. 2020 Jan 1;32(1):35-59. doi: 10.1089/ars.2019.7743.

PMID:
31656084
7.

Prognostic value of blood biomarkers in patients with unprovoked acute pulmonary embolism.

Lee JH, Huh JW, Hong SB, Oh YM, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Lee JS.

Ann Thorac Med. 2019 Oct-Dec;14(4):248-253. doi: 10.4103/atm.ATM_62_19.

8.

Association of plasma fibrinogen concentrations and blood eosinophil counts with clinical phenotypes of COPD.

Hyun DG, Lee JH, Oh YM, Lee SW, Lee SD, Lee JS.

Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1035-1041. doi: 10.5588/ijtld.18.0630.

PMID:
31615613
9.

Analysis of high predicted pulmonary function: possibility of overestimation in small elderly examinees.

Chang Y, Kim HC, Jo KW, Lee JS, Oh YM, Lee SD, Lee SW.

Korean J Intern Med. 2020 Jan;35(1):142-149. doi: 10.3904/kjim.2018.305. Epub 2019 Oct 17.

10.

Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort.

Kim MA, Suh MK, Park J, Kim JH, Kim TH, Kim EK, Oh YM, Lee SD, Lee JH.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 20;14:2135-2144. doi: 10.2147/COPD.S203715. eCollection 2019.

11.

Tobacco company strategies for maintaining cigarette advertisements and displays in retail chain stores: In-depth interviews with Korean convenience store owners.

Hwang JE, Oh YM, Yang YS, Lee SY, Lee JE, Cho SI.

Tob Induc Dis. 2018 Oct 3;16:46. doi: 10.18332/tid/94829. eCollection 2018.

12.

Differences in visual fixation duration according to the position of graphic health warning labels: An eye-tracking approach.

Hwang JE, Yang YS, Oh YM, Lee SY, Lee JE, Cho SI.

Tob Induc Dis. 2018 Sep 4;16:39. doi: 10.18332/tid/94327. eCollection 2018.

13.

Outcome of Regular Inhaled Treatment in GOLD A Chronic Obstructive Pulmonary Disease Patients.

Cho J, Lee CH, Hwang YI, Lee JH, Kim TH, Lee JH, Oh YM, Yoo KH, Jung KS, Lee SD; on behalf of the KOLD and KOCOSS Investigators.

Respiration. 2019;98(4):312-320. doi: 10.1159/000495756. Epub 2019 Aug 28.

PMID:
31461718
14.

Analysis of Drug Release Behavior Utilizing the Swelling Characteristics of Cellulosic Nanofibers.

Ko SW, Lee JY, Lee J, Son BC, Jang SR, Aguilar LE, Oh YM, Park CH, Kim CS.

Polymers (Basel). 2019 Aug 21;11(9). pii: E1376. doi: 10.3390/polym11091376.

15.

Clinical characteristics and economic burden of tuberculous-destroyed lung in Korea: a National Health Insurance Service-National Sample Cohort-based study.

Lee HY, Han DJ, Kim KJ, Kim TH, Oh YM, Rhee CK.

J Thorac Dis. 2019 Jun;11(6):2324-2331. doi: 10.21037/jtd.2019.06.14.

16.

Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD.

Park TS, Kang J, Lee JS, Oh YM, Lee SD, Lee SW.

Int J Chron Obstruct Pulmon Dis. 2019 Apr 16;14:871-879. doi: 10.2147/COPD.S191033. eCollection 2019.

17.

Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease.

Hyun DG, Oh YM, Lee SW, Lee SD, Lee JS.

J Korean Med Sci. 2019 Jul 29;34(29):e195. doi: 10.3346/jkms.2019.34.e195.

18.

Clinical Utility of Quantitative CT Analysis for Fissure Completeness in Bronchoscopic Lung Volume Reduction: Comparison between CT and Chartis™.

Lee SW, Shin SY, Park TS, Choi YY, Park JC, Park J, Oh SY, Kim N, Lee SH, Lee JS, Seo JB, Oh YM, Lee SD, Lee SM.

Korean J Radiol. 2019 Jul;20(7):1216-1225. doi: 10.3348/kjr.2018.0724.

19.

Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation.

Park HJ, Kim SH, Kim HC, Lee BY, Lee SW, Lee JS, Lee SD, Seo JB, Oh YM.

Tuberc Respir Dis (Seoul). 2019 Jul;82(3):234-241. doi: 10.4046/trd.2018.0087. Epub 2019 May 31.

20.

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.

Lee JH, Oh YM, Lee SD, Lee JS.

J Korean Med Sci. 2019 Jun 2;34(21):e160. doi: 10.3346/jkms.2019.34.e160.

21.

A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer.

Lee JH, Hyun DG, Choi CM, Lee JC, Kim WS, Oh YM, Lee SD, Lee JS.

Respiration. 2019;98(3):203-211. doi: 10.1159/000499895. Epub 2019 May 16.

PMID:
31096241
23.

Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.

Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, Lee JS, Lee SW, Oh YM, Ra SW, Kim SH, Sohn JW, Yoon HJ, Lee H.

Eur Respir J. 2019 Aug 29;54(2). pii: 1900194. doi: 10.1183/13993003.00194-2019. Print 2019 Aug. No abstract available.

PMID:
31048349
24.

Bronchial Thermoplasty in Patients with Severe Uncontrolled Asthma: First Korean Cases.

Kang J, Cho YS, Choi DK, Lee JS, Oh YM, Lee SD, Lee SW.

J Korean Med Sci. 2019 Apr 22;34(15):e120. doi: 10.3346/jkms.2019.34.e120.

25.

The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.

Kwon BS, Lee JH, Koh Y, Kim WS, Song JW, Oh YM, Lee SD, Lee SW, Lee JS, Lim CM, Choi CM, Huh JW, Hong SB, Shim TS, Jo KW.

Respir Med. 2019 Apr;150:45-50. doi: 10.1016/j.rmed.2019.02.007. Epub 2019 Feb 12.

PMID:
30961950
26.

Evaluation and Interpretation of Transcriptome Data Underlying Heterogeneous Chronic Obstructive Pulmonary Disease.

Ham S, Oh YM, Roh TY.

Genomics Inform. 2019 Mar;17(1):e2. doi: 10.5808/GI.2019.17.1.e2. Epub 2019 Mar 31.

27.

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.

Lee SH, Lee JH, Yoon HI, Park HY, Kim TH, Yoo KH, Oh YM, Jung KS, Lee SD, Lee SW.

Respir Res. 2019 Mar 28;20(1):62. doi: 10.1186/s12931-019-1029-7.

28.

Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke.

Cho J, Lee CH, Hwang SS, Kim KU, Lee SH, Park HY, Park SJ, Min KH, Oh YM, Yoo KH, Jung KS; KOLD and KOCOSS Investigators.

BMC Pulm Med. 2019 Mar 22;19(1):68. doi: 10.1186/s12890-019-0833-7.

29.

Prediction of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Quantitative CT Parameters.

Koo HJ, Lee SM, Seo JB, Lee SM, Kim N, Oh SY, Lee JS, Oh YM.

Korean J Radiol. 2019 Apr;20(4):683-692. doi: 10.3348/kjr.2018.0391.

30.

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation.

Kim HC, Kim TH, Rhee CK, Han M, Oh YM.

Ther Clin Risk Manag. 2019 Mar 5;15:377-387. doi: 10.2147/TCRM.S194324. eCollection 2019.

31.

Resting hyperinflation and emphysema on the clinical course of COPD.

Kim YW, Lee CH, Hwang HG, Kim YI, Kim DK, Oh YM, Lee SH, Kim KU, Lee SD.

Sci Rep. 2019 Mar 6;9(1):3764. doi: 10.1038/s41598-019-40411-1.

32.

Prediction of Treatment Response in Patients with Chronic Obstructive Pulmonary Disease by Determination of Airway Dimensions with Baseline Computed Tomography.

Park HJ, Lee SM, Choe J, Lee SM, Kim N, Lee JS, Oh YM, Seo JB.

Korean J Radiol. 2019 Feb;20(2):304-312. doi: 10.3348/kjr.2018.0204.

33.
34.

Human umbilical cord blood mesenchymal stem cells expansion via human fibroblast-derived matrix and their potentials toward regenerative application.

Van SY, Noh YK, Kim SW, Oh YM, Kim IH, Park K.

Cell Tissue Res. 2019 May;376(2):233-245. doi: 10.1007/s00441-018-2971-2. Epub 2019 Jan 4.

PMID:
30610451
35.

Disparities in the utilisation of preventive health services by the employment status: An analysis of 2007-2012 South Korean national survey.

Kim S, Song JH, Oh YM, Park SM.

PLoS One. 2018 Dec 26;13(12):e0207737. doi: 10.1371/journal.pone.0207737. eCollection 2018.

36.

Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome.

Na YS, Jang S, Hong S, Oh YM, Lee SD, Lee JS.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):53-61. doi: 10.4046/trd.2018.0045.

37.

Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation.

Kim TH, Rhee CK, Oh YM.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):35-41. doi: 10.4046/trd.2018.0050.

38.

Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration.

Oh YM, Mahar M, Ewan EE, Leahy KM, Zhao G, Cavalli V.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12417-E12426. doi: 10.1073/pnas.1812518115. Epub 2018 Dec 10.

39.

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts.

Song JH, Lee CH, Um SJ, Park YB, Yoo KH, Jung KS, Lee SD, Oh YM, Lee JH, Kim EK, Kim DK; KOLD, KOCOSS, and SNU airway registry investigators.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3473-3484. doi: 10.2147/COPD.S177238. eCollection 2018.

40.

Fabrication of a Micro/Nano-Net Membrane Using Cellulose Nanocrystals Derived from Seaweed.

Ko SW, Lee JY, Aguilar LE, Oh YM, Park CH, Kim CS.

J Nanosci Nanotechnol. 2019 Apr 1;19(4):2232-2235. doi: 10.1166/jnn.2019.15989.

PMID:
30486974
41.

Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.

Kim MH, Kim SH, Park SY, Ban GY, Kim JH, Jung JW, Moon JY, Song WJ, Kwon HS, Kwon JW, Lee JH, Kang HR, Park JS, Kim TB, Park HW, Yoo KH, Oh YM, Koh YI, Jang AS, Lee BJ, Cho YJ, Cho SH, Park HS, Park CS, Yoon HJ, Cho YS.

Allergy Asthma Immunol Res. 2019 Jan;11(1):43-54. doi: 10.4168/aair.2019.11.1.43.

42.

Blood eosinophil count as a prognostic biomarker in COPD.

Oh YM, Lee KS, Hong Y, Hwang SC, Kim JY, Kim DK, Yoo KH, Lee JH, Kim TH, Lim SY, Rhee CK, Yoon HK, Lee SY, Park YB, Jung JH, Kim WJ, Lee SD, Park JH.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 31;13:3589-3596. doi: 10.2147/COPD.S179734. eCollection 2018.

43.

The role of FGF-2 in smoke-induced emphysema and the therapeutic potential of recombinant FGF-2 in patients with COPD.

Kim YS, Hong G, Kim DH, Kim YM, Kim YK, Oh YM, Jee YK.

Exp Mol Med. 2018 Nov 14;50(11):150. doi: 10.1038/s12276-018-0178-y.

44.

Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease.

Kim TH, Oh DK, Oh YM, Lee SW, Do Lee S, Lee JS.

J Thorac Dis. 2018 Sep;10(9):5260-5268. doi: 10.21037/jtd.2018.08.52.

45.

Quantitative assessment of pulmonary vascular alterations in chronic obstructive lung disease: Associations with pulmonary function test and survival in the KOLD cohort.

Cho YH, Lee SM, Seo JB, Kim N, Bae JP, Lee JS, Oh YM, Do-Lee S.

Eur J Radiol. 2018 Nov;108:276-282. doi: 10.1016/j.ejrad.2018.09.013. Epub 2018 Sep 15.

PMID:
30396668
46.

Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of Fmr1 Knock-Out Mice.

Deng PY, Carlin D, Oh YM, Myrick LK, Warren ST, Cavalli V, Klyachko VA.

J Neurosci. 2019 Jan 2;39(1):28-43. doi: 10.1523/JNEUROSCI.1593-18.2018. Epub 2018 Nov 2.

47.

Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells.

Park JS, Kim HK, Kang EY, Cho R, Oh YM.

Tuberc Respir Dis (Seoul). 2019 Apr;82(2):158-165. doi: 10.4046/trd.2018.0044. Epub 2018 Sep 28.

48.

Dilemma of Asthma Treatment in Mild Patients.

Cho YS, Oh YM.

Tuberc Respir Dis (Seoul). 2019 Jul;82(3):190-193. doi: 10.4046/trd.2018.0013. Epub 2018 Sep 28. Review.

49.

Convenience store visitors recall cigarette advertisements even if they do not purchase cigarettes.

Hwang JE, Cho SI, Yang YS, Lee JE, Lee SY, Oh YM.

J Public Health (Oxf). 2019 Dec 20;41(4):732-741. doi: 10.1093/pubmed/fdy166.

50.

Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?

Kokturk N, Yıldırım F, Gülhan PY, Oh YM.

Am J Stem Cells. 2018 Aug 1;7(3):56-71. eCollection 2018. Review.

Supplemental Content

Support Center